S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
Top Innovation Stock (Ad)
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Top Innovation Stock (Ad)
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Top Innovation Stock (Ad)
Chevron Delights Shareholders with $75 Billion in Share Buybacks
Mergers and Acquisitions in 2023 Off To A Strong Start
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
Top Innovation Stock (Ad)
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Top Innovation Stock (Ad)
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Top Innovation Stock (Ad)
Chevron Delights Shareholders with $75 Billion in Share Buybacks
Mergers and Acquisitions in 2023 Off To A Strong Start
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
Top Innovation Stock (Ad)
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Top Innovation Stock (Ad)
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Top Innovation Stock (Ad)
Chevron Delights Shareholders with $75 Billion in Share Buybacks
Mergers and Acquisitions in 2023 Off To A Strong Start
S&P 500   3,852.36
DOW   32,920.46
QQQ   293.34
Mullen Automotive: The Good News, The Bad And The Ugly Outlook 
Top Innovation Stock (Ad)
A Non-Salesy Annuity Guide To Buying Annuities
3 Small Caps That Have Big Upside
Top Innovation Stock (Ad)
Levi Strauss Is A Good Fit For Income Investors 
What Does Apple's Move to India Mean for Investors?
Top Innovation Stock (Ad)
Chevron Delights Shareholders with $75 Billion in Share Buybacks
Mergers and Acquisitions in 2023 Off To A Strong Start
NYSE:CRI

Carter's - CRI Stock Forecast, Price & News

$80.59
-0.94 (-1.15%)
(As of 01/26/2023 12:00 AM ET)
Add
Compare
Today's Range
$79.10
$81.15
50-Day Range
$69.31
$83.77
52-Week Range
$62.65
$100.07
Volume
967,804 shs
Average Volume
500,026 shs
Market Capitalization
$3.08 billion
P/E Ratio
12.27
Dividend Yield
3.68%
Price Target
$82.25

Carter's MarketRank™ Forecast

Analyst Rating
Hold
1.60 Rating Score
Upside/​Downside
2.1% Upside
$82.25 Price Target
Short Interest
Healthy
5.39% of Float Sold Short
Dividend Strength
Strong
Based on Four Factors
Sustainability
-3.31
Upright™ Environmental Score
News Sentiment
0.10mentions of Carter
Based on 9 Articles This Week
Insider Trading
Selling Shares
$6.94 M Sold Last Quarter
Proj. Earnings Growth
6.44%
From $6.37 to $6.78 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.86 out of 5 stars

Consumer Discretionary Sector

239th out of 275 stocks

Apparel, Finished Products From Fabrics & Similar Materials Industry

12th out of 13 stocks


CRI stock logo

About Carter's (NYSE:CRI) Stock

Carter's, Inc. engages in the marketing of apparel for babies and young children. It operates through the following segments: U.S. Retail, U.S. Wholesale, and International. The U.S. retail segment consists of sales of products in retail and online stores. The U.S. Wholesale segment includes sales in the United States of products to wholesale partners. The International segment consists of sales of products outside the United States, largely through retail stores in Canada and Mexico, eCommerce sites in Canada and China, and sales to international wholesale accounts and licensees. The company was founded by William Carter in 1865 and is headquartered in Atlanta, GA.

Receive CRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carter's and its competitors with MarketBeat's FREE daily newsletter.

CRI Stock News Headlines

Today's Featured Press Release
Small Pharma just reported clinical trial results.
The Returns At Carter's (NYSE:CRI) Aren't Growing
Today's Featured Press Release
Small Pharma just reported clinical trial results.
Why Carter's Stock Was Flopping on Friday
Carter's (CRI) Q3 Earnings Top Estimates
See More Headlines
Receive CRI Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Carter's and its competitors with MarketBeat's FREE daily newsletter.

CRI Company Calendar

Last Earnings
10/28/2021
Ex-Dividend for 12/9 Dividend
11/28/2022
Dividend Payable
12/09/2022
Today
1/27/2023
Next Earnings (Estimated)
2/24/2023
Fiscal Year End
12/31/2023

Industry, Sector and Symbol

Industry
Apparel, finished products from fabrics & similar materials
Sub-Industry
Apparel Accessories & Luxury Goods
CUSIP
14622910
Employees
15,900
Year Founded
1865

Price Target and Rating

Average Stock Price Forecast
$82.25
High Stock Price Forecast
$99.00
Low Stock Price Forecast
$68.00
Forecasted Upside/Downside
+2.1%
Consensus Rating
Hold
Rating Score (0-4)
1.60
Research Coverage
5 Analysts

Profitability

Net Income
$339.75 million
Pretax Margin
10.10%

Debt

Sales & Book Value

Annual Sales
$3.49 billion
Cash Flow
$10.28 per share
Book Value
$22.48 per share

Miscellaneous

Free Float
36,788,000
Market Cap
$3.08 billion
Optionable
Optionable
Beta
1.21

Social Links


Key Executives

  • Michael Dennis Casey
    Chairman & Chief Executive Officer
  • Brian J. LynchBrian J. Lynch
    President
  • Richard F. Westenberger
    CFO, Chief Accounting Officer & Executive VP
  • Benjamin L. Pivar
    Chief Information Officer & Senior Vice President
  • Sean McHugh
    Treasurer & Vice President













CRI Stock - Frequently Asked Questions

Should I buy or sell Carter's stock right now?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Carter's in the last twelve months. There are currently 2 sell ratings and 3 hold ratings for the stock. The consensus among Wall Street analysts is that investors should "hold" CRI shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in CRI, but not buy additional shares or sell existing shares.
View CRI analyst ratings
or view top-rated stocks.

What is Carter's' stock price forecast for 2023?

5 Wall Street research analysts have issued 12 month price targets for Carter's' shares. Their CRI share price forecasts range from $68.00 to $99.00. On average, they expect the company's stock price to reach $82.25 in the next year. This suggests a possible upside of 2.1% from the stock's current price.
View analysts price targets for CRI
or view top-rated stocks among Wall Street analysts.

How have CRI shares performed in 2023?

Carter's' stock was trading at $74.61 on January 1st, 2023. Since then, CRI shares have increased by 8.0% and is now trading at $80.59.
View the best growth stocks for 2023 here
.

Are investors shorting Carter's?

Carter's saw a decline in short interest during the month of January. As of January 15th, there was short interest totaling 2,010,000 shares, a decline of 7.4% from the December 31st total of 2,170,000 shares. Based on an average daily volume of 651,800 shares, the short-interest ratio is currently 3.1 days. Approximately 5.4% of the shares of the stock are short sold.
View Carter's' Short Interest
.

When is Carter's' next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Friday, February 24th 2023.
View our CRI earnings forecast
.

How were Carter's' earnings last quarter?

Carter's, Inc. (NYSE:CRI) posted its quarterly earnings results on Friday, October, 28th. The textile maker reported $1.67 EPS for the quarter, beating the consensus estimate of $1.65 by $0.02. The textile maker had revenue of $818.60 million for the quarter, compared to analysts' expectations of $853.63 million. Carter's had a trailing twelve-month return on equity of 44.06% and a net margin of 7.94%. The business's quarterly revenue was down 8.1% on a year-over-year basis. During the same period last year, the firm earned $1.93 EPS.

How often does Carter's pay dividends? What is the dividend yield for Carter's?

Carter's announced a quarterly dividend on Thursday, November 17th. Shareholders of record on Tuesday, November 29th will be given a dividend of $0.75 per share on Friday, December 9th. This represents a $3.00 annualized dividend and a dividend yield of 3.72%. The ex-dividend date of this dividend is Monday, November 28th.
Read our dividend analysis for CRI
.

Is Carter's a good dividend stock?

Carter's (NYSE:CRI) pays an annual dividend of $3.00 per share and currently has a dividend yield of 3.68%. The company does not yet have a strong track record of dividend growth. The dividend payout ratio is 45.66%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, CRI will have a dividend payout ratio of 44.25% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for CRI.

What guidance has Carter's issued on next quarter's earnings?

Carter's issued an update on its fourth quarter 2022 earnings guidance on Sunday, November, 6th. The company provided earnings per share (EPS) guidance of $1.40-$2.00 for the period, compared to the consensus earnings per share estimate of $2.56. The company issued revenue guidance of $845.00 million-$885.00 million, compared to the consensus revenue estimate of $963.82 million.

What is Mike Casey's approval rating as Carter's' CEO?

469 employees have rated Carter's Chief Executive Officer Mike Casey on Glassdoor.com. Mike Casey has an approval rating of 86% among the company's employees.

What other stocks do shareholders of Carter's own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Carter's investors own include CVS Health (CVS), Cisco Systems (CSCO), Home Depot (HD), Intel (INTC), QUALCOMM (QCOM), Starbucks (SBUX), Skyworks Solutions (SWKS), Alphabet (GOOG), Walt Disney (DIS) and Netflix (NFLX).

What is Carter's' stock symbol?

Carter's trades on the New York Stock Exchange (NYSE) under the ticker symbol "CRI."

Who are Carter's' major shareholders?

Carter's' stock is owned by a number of institutional and retail investors. Top institutional shareholders include Boston Trust Walden Corp (2.53%), Reinhart Partners Inc. (0.60%), Ceredex Value Advisors LLC (0.49%), Hahn Capital Management LLC (0.25%), Sound Income Strategies LLC (0.17%) and Coho Partners Ltd. (0.14%). Insiders that own company stock include Ben Pivar, Brian Lynch, Jill Wilson, Julie D'emilio, Kendra Krugman, Michael Dennis Casey and William J Montgoris.
View institutional ownership trends
.

How do I buy shares of Carter's?

Shares of CRI stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Carter's' stock price today?

One share of CRI stock can currently be purchased for approximately $80.59.

How much money does Carter's make?

Carter's (NYSE:CRI) has a market capitalization of $3.08 billion and generates $3.49 billion in revenue each year. The textile maker earns $339.75 million in net income (profit) each year or $6.57 on an earnings per share basis.

How many employees does Carter's have?

The company employs 15,900 workers across the globe.

Does Carter's have any subsidiaries?
The following companies are subsidiares of Carter's: Skip Hop.
Read More
How can I contact Carter's?

Carter's' mailing address is 3438 PEACHTREE ROAD NE SUITE 1800 PHIPPS TOWER, ATLANTA GA, 30326. The official website for the company is www.carters.com. The textile maker can be reached via phone at (678) 791-1000, via email at investor@carters.com, or via fax at 404-892-3079.

This page (NYSE:CRI) was last updated on 1/27/2023 by MarketBeat.com Staff